Notice ID: 8687853b2b6f930be107961bbb9b8e7fCombined Synopsis/Solicitation
NMCP RADIOPHARMACEUTICALS
Archived on January 1, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−05:00
- Posted
- October 15, 2019
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of WarDepartment of the Navy
Notice details
- Office
- NAVAL MEDICAL LOGISTICS COMMAND
- PSC
- 65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- N6264519R0087
- Notice ID
- 8687853b2b6f930be107961bbb9b8e7f
Description
See attachment.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
N6264519R0087- Combined Synopsis
- 2×Combined SynopsisCurrentSep 30, 2019
NMCP RADIOPHARMACEUTICALS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Acquisition Description: This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Cardinal Health. This requirement will be sole sourced to Cardinal Health under FAR 13.501(a) or 8.405-6 (b) - sole source requirements. The National Institutes of Health (NIH) Clinical Center (CC) (NIH-CC or “Program”) is a clinical research hospital providing all medical services for patients participating in human research protocols of the NIH. The CC Pharmacy department provides a range of pharmaceutical care services to inpatients and outpatients enrolled in clinical trials. The CC Pharmacy department is responsible for acquiring the supply of medications required for patient care. The NIH-CC has a pharmacy center that requires Sirturo (Bedaquiline) drug tablets for patient care. Sirturo is supplied in the following forms: 100 mg tablets in 188 count bottles and 20 mg tablets in 60 count bottles. Various different quantities are needed every year. Based on Program’s purchase history in the past, and factoring in the anticipated patient enrollment, Program expects to need approximately 12 - 36 bottles of each type of Sirturo® bottles per year. Justification: Only this Sirturo medication can be accepted as there are no substitutes for this medication. The manufacturer (Janssen Therapeutics) has designated Cardinal Health (DBA Metro Medical Supply) as the sole distributor of Sirturo in the U.S. Previous acquisitions and research indicated that this requirement should be a sole source requirement. For the previous acquisitions, Notice of Intent notices were posted on SAM.gov. Cardinal Health/Metro Medical was the only sole source provider. In order to confirm this is still applicable, this requirement was previously posted on SAM.gov as an RFQ under full and open competition under RFQ-CC-24-008485. No other companies responded, and it was confirmed by this posting that they are the sole source vendor. Previous acquisitions and research revealed this requirement should be a sole source requirement. More recently, a Request for Quotes was posted under RFQ-CC-24-008485 and it was reconfirmed that Cardinal Health/Metro Medical is the sole source vendor as they are the official authorized reseller of this equipment via their relationship with the manufacturer. Thus, Cardinal Health/Metro Medical is the only responsible and authorized source for Sirturo. Requirements: SIRTURO (BEDAQUILINE) 100 mg tablet in 188-count bottles (NDC# 59676070101) SIRTURO (BEDAQUILINE) 20 mg tablet in 60-count bottles (NDC#59676070260) Period of performance/Date of Delivery: Within 30 days of award, or mutually agreed upon. Place of Performance or Delivery: Place of Performance: NIH Clinical Center in Bethesda, MD The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-27-000056) by 04:00 PM eastern standard time on 11/11/2026 to: lu-chang.lu@nih.gov All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | - | Pre-Solicitation | 11/11/2026 |
The Defense Health Agency (DHA) Contracting Activity (DHACA), on behalf of the DHA’s Portfolio Acquisition Executive Medical Products (PAE MP), intends to issue a firm-fixed price Indefinite Delivery/Indefinite Quantity contract on a sole source basis under the authority of the Revolutionary Federal Acquisition Regulation (FAR) Overhaul, FAR 6.103-1, only one responsible source and no other supplies or services will satisfy agency requirements, to Vascular Solutions LLC, 6420 Sycamore Ct N, Maple Grove, Minnesota 55369-6032. Vascular Solutions, LLC is the only source able to meet the Government’s requirements. The Government has a has a critical requirement for supply of a Food and Drug Administration (FDA) approved Freeze Dried Plasma (FDP) product for transfusion when plasma is required and other plasma products are not available. The FDA approved Vascular Solutions, LLC FDP product, EZPLAZ™, on 29 July 2026. Vascular Solutions LLC holds the first and only FDA-approved (licensed) FPD product on the market. This Notice of Intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Responses must be supported with clear and convincing evidence articulating the ability to provide FDA approved FDP product. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. If no written responses are received by the date listed below, an Indefinite Delivery/Indefinite Quantity contract will be awarded without further remark. Capability statements are due by 3:00 PM local time, 16 September 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: timothy.j.kelly169.civ@health.mil and shannon.p.lertora.civ@health.mil. | - | Special Notice | 09/16/2026 |
General Information This is a solicitation for commercial products prepared in accordance with the format in Federal Acquisition Regulation (FAR)/Revolutionary FAR Overhaul (RFO) Subpart 12.201, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a separate written solicitation will not be issued. Naval Surface Warfare Center Indian Head Division (NSWC IHD), located in Indian Head, Maryland, intends to award a firm-fixed-price (FFP) purchase order using Simplified Acquisition Procedures to Procure for Bulk Cryogenics. Solicitation Details Quotes are being requested under Request for Quotations (RFQ) Amendment N0017426Q11180001. The applicable North American Industry Classification System (NAICS) code is 325120 and the associated small business size standard is 1200 employees. The solicitation document and incorporated provisions and clauses are those in effect through the FAR/RFO. This RFQ incorporates all provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01 and the Defense Federal Acquisition Regulation Supplement (DFARS) DPN 20260507. Basis for Award The Government will award a purchase order resulting from this solicitation to the responsible vendor whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The Government intends to evaluate all timely quotes received from eligible vendors on a Lowest Price Technically Acceptable (LPTA) basis. The Government intends to evaluate quotations and award a purchase order without discussion. Evaluation Factors: Technical: Quotes must reflect the required specifications and the exact brand specified in the Statement of Work. Price: Quotes must include all applicable costs, including shipping and handling. Submission Instructions Quote packages are due by November 05, 2026, at 10:00 AM EST. Late quotes will not be considered. Quote packages shall be sent via email to latrice.t.whitfield.civ@us.navy.mil and must contain a cover sheet that provides the following information: Official Company Name; Point of Contact (including name, email address, and phone number); and Unique Entity Identifier (UEI) and CAGE Code. | - | Solicitation | 11/05/2026 |
This is a Request for Information (RFI) only. This RFI is issued solely for information and planning purposes and does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This RFI does not commit the Government to contract for any supply or service whatsoever. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI. The purpose of this RFI is to conduct market research to identify potential vendors with products available that meets the capability criteria listed in this document. | - | Market Research | 11/23/2026 |
THIS IS A NOTICE OF INTENT TO SOLE SOURCE, NOT A REQUEST FOR A QUOTE (RFQ). A SOLICITATION WILL NOT BE ISSUED AND QUOTES WILL NOT BE REQUESTED. The Naval Surface Warfare Center Indian Head Division (NSWC IHD) intends to award a firm-fixed-price contract on a non-competitive basis to Cartridge Actuated Devices, Inc. (CAGE: 16148), located at 51 Dwight Pl, Fairfield, NJ 07004, for the acquisition of the following supply: Item Description: Squibs for Fire Sprinkler Valves (Primer, Part Number: 074080-3) Quantity: 50 Units This action is being undertaken in accordance with FAR 13.106-1(b)(1) on the basis that Cartridge Actuated Devices, Inc. is the only known source capable of meeting the Government’s requirements, utilizing the simplified procedures for certain commercial items authorized under 41 U.S.C. 1901 (implemented by FAR Subpart 13.5). The North American Industry Classification System (NAICS) code for this requirement is 325920 (Explosives Manufacturing), and the Federal Supply Code (FSC) is 1377 (Cartridge and Propellant Actuated Devices and Components). This Notice of Intent is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this requirement. All capability statements received by November 03, 2026, at 10:00 AM EST will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Interested vendors must be registered in the System for Award Management (SAM) database at https://www.sam.gov prior to submission. Responses must be submitted electronically via email to Shannon Wooten, Contract Specialist, at shannon.d.cloud-wooten.civ@us.navy.mil (or shannon.cloud-wooten@navy.mil) no later than 10:00 AM EST on November 03, 2026. | - | Special Notice | 11/03/2026 |
Additional Details
Solicitation Number
N6264519R0087
Archive Date
Jan 1, 2022
Office Address
FORT DETRICK, MD, 21702-9203